Livzon Pharmaceutical Group Inc. clinical trials

Acquired by Joincare Pharmaceutical Group Industry Co., Ltd., 2002 · source ↗

The registry lists 28 studies whose lead sponsor is Livzon Pharmaceutical Group Inc.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 5, 2026.

Studies

Recruiting first, then most recently updated. Showing 28 of 28. All Joincare Pharmaceutical Group Industry Co., Ltd. studies →

• Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee ArthroplastyRecruitingNCT06963320Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux EsophagitisRecruitingNCT06850480Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• A Study to Evaluate the Efficacy and Safety of LZM012RecruitingNCT06110676Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis )CompletedNCT07746479Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer BleedingCompletedNCT05841394Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)CompletedNCT05050474Phase 1

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster StudyCompletedNCT05096832Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase IIIStatus unknownNCT05096845Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5Status unknownNCT05585567Early Phase 1

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351Status unknownNCT05583357Early Phase 1

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein VaccineStatus unknownNCT05238649Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• The Immunogenicity and Safety of V-01-351/V-01D Bivalence VaccineStatus unknownNCT05273528Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and ImmunogencityStatus unknownNCT05239832Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster ImmunizationStatus unknownNCT05125874Not applicable

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• LZM009 to Treat Patients With Advanced Solid TumorsCompletedNCT03286296Phase 1

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in USCompletedNCT04026321Phase 1

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract .Status unknownNCT03456609Not applicable

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract .Status unknownNCT03455205Not applicable

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese PatientsCompletedNCT03362281Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese PatientsCompletedNCT03362268Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter PyloriCompletedNCT02873065Phase 4

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese PatientsCompletedNCT02860624Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedNCT02847455Phase 2/3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori InfectionCompletedNCT02835560Phase 4

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Clinical Research on Effectiveness and Safety of Treatment of Severe Oligospermia or Azoospermia With uFSHStatus unknownNCT02307994Phase 4

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese PatientsStatus unknownNCT01107938Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)CompletedNCT00953381Phase 2

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.

• Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)CompletedNCT00952978Phase 3

  Sponsor listed in the registry: Livzon Pharmaceutical Group Inc. · First submitted after Livzon Pharmaceutical Group Inc. became part of Joincare Pharmaceutical Group Industry Co., Ltd.